功能性肝脏影像评分与相对增强指数预测肝硬化无移植生存
结果显示FLIS和REI观察者间一致性极佳(ICC均为0.97),FLIS 0-3分在调整年龄、MELD和Child-Pugh评分后仍独立预测不良结局(校正HR 2.64,95% CI 1.10-6.34,p=0.030),而REI<100在多变量调整后未达统计学显著性(校正HR 2.67,95% CI 0.94-7.58,p=0.065)。竞争风险分析提示两种指标与复合终点的关联主要由肝移植事件驱动。
要点
- FLIS与REI观察者间一致性极佳(ICC均为0.97),适合多阅片者场景使用
- FLIS 0-3分提示肝硬化进展至终末期肝病的风险升高,可在报告中标注
- 两指标鉴别效力与MELD、Child-Pugh相当(DeLong p≥0.43),不应替代临床评分
核心结论
- FLIS与REI与肝硬化患者无移植生存相关,AUROC鉴别效力中等(FLIS 0.745,REI 0.703),FLIS在调整年龄、MELD和Child-Pugh后仍保持独立关联
- 竞争风险分析显示两指标与复合终点的关联主要由肝移植事件驱动,应视为终末期肝病进展的可重复影像标志物,而非死亡率的确证预测因子
研究设计与样本
- 两名独立阅片者评估REI与FLIS,用kappa评估FLIS各组分一致性、ICC评估FLIS总分与REI一致性,Cox回归与竞争风险模型分析无移植生存
关键影像表现/征象
- FLIS基于钆塞酸二钠增强MRI肝胆期肝实质信号强度、胆道对比剂排泄及门静脉信号征象综合评分
- REI为相对增强指数,基于增强前后肝实质信号变化计算,具体计算公式原文未提供
- FLIS 0-3分与REI<100为不良结局(死亡或肝移植)的预测界值
诊断标准与关键数值
- FLIS 0-3分预测死亡或肝移植的AUROC为0.745
- REI预测死亡或肝移植的AUROC为0.703
- FLIS 0-3分单变量Cox分析HR 3.767(95% CI 1.872-7.579,p<0.001),REI<100单变量HR 3.883(95% CI 1.679-8.979,p=0.002)
- FLIS 0-3分调整年龄、MELD、Child-Pugh后HR 2.64(95% CI 1.10-6.34,p=0.030),REI<100校正HR 2.67(95% CI 0.94-7.58,p=0.065)
- 竞争风险分析中FLIS 0-3分与REI<100对肝移植累积发生率的次分布HR分别为3.42和6.18,对死亡的次分布HR分别为1.41和1.45
临床应用与阅片要点
- FLIS与REI一致性极佳,可作为肝硬化患者钆塞酸二钠增强MRI报告中可重复的肝储备功能影像学评估工具
- FLIS 0-3分提示肝硬化进展至终末期肝病的风险升高,值得在报告中标注并建议密切临床随访
- 两种指标不能替代MELD或Child-Pugh评分,但可作为补充信息辅助多学科讨论肝移植时机
局限性
- 分层抽样设计使生存率不适用于人群水平外推
- 原文未说明REI具体计算公式与FLIS各组分评分细则的详细操作标准
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the prognostic performance of the Relative Enhancement Index (REI) and the Functional Liver Imaging Score (FLIS), derived from gadoxetic acid-enhanced MRI, for predicting transplant-free survival in patients with cirrhosis; to determine whether these imaging biomarkers provide prognostic information after adjustment for clinical severity markers; to assess their interobserver agreement; and, because transplantation and death are competing events, to disentangle the association of FLIS and REI with each outcome using a competing-risks framework.
METHODS: In this retrospective study, cirrhotic patients who underwent gadoxetic acid-enhanced MRI between September 2014 and August 2018 were included and followed for up to eight years for transplant-free survival. The cohort was assembled using stratified convenience sampling, with 20 patients selected from each Child-Pugh class (A, B, and C), to ensure representation across the full spectrum of liver dysfunction. Two independent readers assessed the Relative Enhancement Index (REI) and the Functional Liver Imaging Score (FLIS). Interobserver agreement was evaluated using kappa statistics for the individual FLIS components and ICC for the total FLIS score and REI. Transplant-free survival was analyzed using Kaplan-Meier curves, the log-rank test, and Cox proportional hazards regression. Multivariable Cox regression models were constructed separately for FLIS and REI, adjusted for age, MELD score, and Child-Pugh score. A sensitivity analysis was additionally performed by treating liver transplantation as a censoring event and all-cause death as the only event of interest. In addition, a competing-risks analysis was performed using cumulative incidence functions, Gray's test, and Fine-Gray subdistribution hazard models, with death and liver transplantation analysed alternately as the event of interest. Discrimination was compared with MELD and Child-Pugh score using DeLong's test, and incremental value was assessed by the change in Harrell's C-index with likelihood-ratio testing. The proportional hazards assumption was tested with Schoenfeld residuals, and a 30-day landmark analysis was performed.
RESULTS: Sixty patients were included (32 men; median age, 58 years; interquartile range [IQR], 51-64 years), with 20 patients in each Child-Pugh class by design. During follow-up, 20 patients underwent liver transplantation (33.3 %), 16 died (26.7 %), and 24 remained alive without transplantation (40 %). Interobserver agreement was excellent for both FLIS (ICC = 0.97) and REI (ICC = 0.97). Because the cohort was deliberately stratified by Child-Pugh class, absolute transplant-free survival estimates were considered cohort-specific and not interpreted as population-level survival rates. AUROC values showed moderate discrimination for the composite endpoint of death or liver transplantation (FLIS, 0.745; REI, 0.703). In univariable Cox analysis, FLIS 0-3 and REI < 100 were significant predictors of adverse outcomes (death or liver transplantation), with hazard ratios of 3.767 (95 % CI: 1.872-7.579; p < 0.001) and 3.883 (95 % CI: 1.679-8.979; p = 0.002), respectively. After adjustment for age, MELD score, and Child-Pugh score, FLIS 0-3 remained independently associated with transplant-free survival (adjusted HR, 2.64; 95 % CI: 1.10-6.34; p = 0.030), whereas the association for REI < 100 was of similar magnitude but did not reach statistical significance (adjusted HR, 2.67; 95 % CI: 0.94-7.58; p = 0.065). In the death-only sensitivity analysis, FLIS remained significantly associated with survival (log-rank p = 0.042), whereas the association for REI was attenuated and did not reach statistical significance (log-rank p = 0.096). Discrimination did not differ significantly from that of MELD (AUROC, 0.731) or Child-Pugh score (AUROC, 0.753; all DeLong p ≥ 0.43), and both indices improved model fit when added to MELD (likelihood-ratio p = 0.004 for both). In competing-risks analysis, FLIS 0-3 and REI < 100 were associated with the cumulative incidence of liver transplantation (subdistribution HR, 3.42 and 6.18, respectively) but not with that of death (1.41 and 1.45).
CONCLUSION: FLIS and REI demonstrate excellent interobserver agreement and are associated with transplant-free survival in patients with cirrhosis, with moderate discriminative performance by AUROC analysis. FLIS remained independently associated with outcome after adjustment for age, MELD score, and Child-Pugh score, whereas REI showed an association of similar magnitude that did not reach significance after multivariable adjustment. Competing-risks analysis indicates that the association of both indices with the composite endpoint is driven predominantly by the transplantation component, and discrimination did not differ from that of MELD or Child-Pugh score. FLIS and REI should therefore be regarded as reproducible imaging markers of progression to end-stage liver disease rather than as validated predictors of mortality.
引用
- Melo Lima, Eiras-Araújo, Souza Rodrigues, et al. Functional liver imaging score and relative enhancement index predict transplant-free survival in cirrhosis. Eur J Radiol. 2026. PMID: 42612460. doi:10.1016/j.ejrad.2026.113162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。